Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:September 13, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:September 13, 2010Completed
Condition(s):Kidney Transplant; Complications; Acute Kidney InjuryLast Updated:October 25, 2021Completed
Condition(s):Sepsis; Septic Shock; Critical Illness; Respiratory Acidosis; Respiratory Alkalosis; Acid-Base ImbalanceLast Updated:June 4, 2019Unknown status
Condition(s):Polymorphism, Genetic; Depression; CYP1A2 Polymorphism; CYP2C9 Polymorphism; Polymerase Chain Reaction; Plasma ConcentrationLast Updated:November 7, 2023Not yet recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:December 7, 2020Unknown status
Condition(s):Periodontitis, Adult; Intrabony Periodontal DefectLast Updated:December 19, 2023Completed
Condition(s):Lymphoma; Chemotherapeutic ToxicityLast Updated:February 15, 2024Recruiting
Condition(s):Acute Coronary SyndromeLast Updated:August 29, 2019Unknown status
Condition(s):Acute Pancreatitis; Systemic Inflammatory Response SyndromeLast Updated:February 22, 2024Recruiting
Condition(s):SepsisLast Updated:January 18, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.